Last reviewed · How we verify

NCT05632172: IBPTHPIBC

Buccal and Palatal Bone Thickness and Marginal Bone Changes Implants

Completed Last updated 30 November 2022
What this trial tests

trial testing implant insertion in Bone Implant; Complications in 90 participants. Completed in 15 September 2021.

Timeline
15 January 2021
Primary endpoint
15 July 2021
15 September 2021

Quick facts

Lead sponsorInternational Piezosurgery Academy
StatusCompleted
Study typeOBSERVATIONAL
Enrollment90
Start date15 January 2021
Primary completion15 July 2021
Estimated completion15 September 2021
Sites2 locations across Italy

Drugs / interventions tested

Conditions studied

Sponsor

International Piezosurgery Academy

Who can join

18 and older, any sex, with Bone Implant; Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary outcome of the study was the vertical variation of peri-implant buccal and palatal bone level from implant placement (T0) to uncovering stage (3 months later - T1)

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Influence of buccal and palatal bone thickness on post-surgical marginal bone changes around implants placed in posterior maxilla: a multi-centre prospective study.
    Cicciù M, Pratella U, Fiorillo L, Bernardello F, et al · · 2023 · cited 10× · PMID 37217911 · DOI 10.1186/s12903-023-02991-3

Verify or expand the search:

Other trials of implant insertion

Trials testing the same drug.

Other International Piezosurgery Academy trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05632172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing